Cargando…

Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?

BACKGROUND: High-mobility group box 1 (HMGB1), identified as an alarmin molecule, was shown to have a role in virus-triggered liver injury. We aimed to evaluate the association between serum levels of HMGB1 and liver fibrosis. METHOD: This cross-sectional case-control study included 189 chronic hepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inkaya, Ahmet Cagkan, Demir, Nazlim Aktug, Kolgelier, Servet, Sumer, Sua, Demir, Lutfi Saltuk, Ural, Onur, Pehlivan, Fatma Seher, Aslan, Mahmure, Arpaci, Abdullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392731/ https://www.ncbi.nlm.nih.gov/pubmed/28885322 http://dx.doi.org/10.1097/MD.0000000000007547

Ejemplares similares

Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B
por: Kolgelier, Servet, et al.
Publicado: (2015)

The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis
por: Sumer, Sua, et al.
Publicado: (2013)

Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters
por: Aktug Demir, Nazlim, et al.
Publicado: (2014)

An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients
por: Demir, Nazlim Aktug, et al.
Publicado: (2023)

An Exercise Prescription for COVID-19 Pandemic
por: Aktug, Zait Burak, et al.
Publicado: (2020)

Texture analysis of multiparametric magnetic resonance imaging for differentiating clinically significant prostate cancer in the peripheral zone
por: ÖZER, Halil, et al.
Publicado: (2023)

Evaluation of systemic involvement of Coronavirus disease 2019 through spleen; size and texture analysis
por: BATUR, Abdussamet, et al.
Publicado: (2021)

Case report—right atrial mass: a very rare presentation of endometrial cancer metastasis
por: Erturk, Emre, et al.
Publicado: (2023)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
por: Yang, Huan, et al.
Publicado: (2019)

High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2
por: Yakabe, K, et al.
Publicado: (2005)

Patient Knowledge, Attitudes, and Behaviors Associated with Organ Donation
por: Uyar, Mehmet, et al.
Publicado: (2019)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
por: Abdulahad, Deena A, et al.
Publicado: (2011)

Expression and purification of functional HMGB1 A box by fusion with SUMO
por: GE, WEN-SONG, et al.
Publicado: (2015)

May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
por: Kara, Emre, et al.
Publicado: (2020)

Chest CT findings in RT-PCR positive asymptomatic COVID-19 patients
por: Uysal, Emine, et al.
Publicado: (2021)

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
por: Chen, Qingjie, et al.
Publicado: (2016)

Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2014)

Developmental expression of high-mobility group box 1 (HMGB1) in the mouse cochlea
por: Liu, Wenjing, et al.
Publicado: (2023)

Evaluation of risk factors, causative pathogens, and treatment in recurrent percutaneous nephrostomy catheter-related urinary tract infections in cancer patients
por: Mert, Duygu, et al.
Publicado: (2022)

Behçet’s Disease-related Budd–Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature
por: Erul, Enes, et al.
Publicado: (2022)

High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
por: Yuan, Shunling, et al.
Publicado: (2020)

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review
por: Ikram, Fathimath Zaha, et al.
Publicado: (2022)

High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy
por: DeWulf, Bram, et al.
Publicado: (2023)

Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
por: Sun, Yan, et al.
Publicado: (2018)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

Actinomyces-associated Lesions Located in the Gingiva: Case Report of Rare Gingival Lesions
por: Acar, Buket, et al.
Publicado: (2017)

Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital
por: CEYLAN, Erdal, et al.
Publicado: (2019)

Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses
por: Arnold, Edward A., et al.
Publicado: (2023)

Propofol Protects Lung Endothelial Barrier Function by Suppression of High-Mobility Group Box 1 (HMGB1) Release and Mitochondrial Oxidative Damage Catalyzed by HMGB1
por: Feng, Zhou, et al.
Publicado: (2019)

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
por: Pisetsky, David S, et al.
Publicado: (2008)

High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
por: Ge, Xiaodong, et al.
Publicado: (2014)

The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

The role of GSTM1 gene polymorphisms in lung cancer development in Turkish population
por: Demir, Adalet, et al.
Publicado: (2007)

Electrocardiographic and Seasonal Patterns Allow Accurate Differentiation of Tako-Tsubo Cardiomyopathy from Acute Anterior Myocardial Infarction: Results of a Multicenter Study and Systematic Overview of Available Studies
por: Çatalkaya Demir, Seher, et al.
Publicado: (2019)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

Single and double box HMGB proteins differentially destabilize nucleosomes
por: McCauley, Micah J, et al.
Publicado: (2019)

Correction: The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression
por: Yasinska, Inna M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rrp76v7eethrune1ehlk2eetbr